CVS Health Corp. Rating and price target update

Morningstar an investment research and management company has given BBB+ rating to CVS Health Corporation.  This rating represents that the health care company stands at a reasonable default risk. Morningstar also gave the company a one star rating.

Various other research firms’ analysts have also reviewed CVS Health stock. Deutsche Bank analysts upraised their target price to $109 from $100 on company’s share and also assigned a rating of Hold on February 13^th research note. Citigroup analysts restated its Hold rating and gave a new target price of $110 increased from $102 on CVS stock also on 13^th February note. Standard & Poor equity research analysts demoted the stock of the company and rated it as Hold on February 11^th research note.in the end , Cantor Fitzgerald analysts repeated it Hold rating and set a new target price of $83 on CVS Corp stock on Wednesday 11^th February note. Out of 22 research analyst covering the stock, two have given it a Sell rating, five assigned a Hold rating and remaining fifteen have rated the stock a Buy. The 12-month target price based on consensus is $98.15.

The American based company reported its October to December quarter earnings last month on 10^th February. According to which it had an earnings of $1.21 per share surpassing $1.20 per share estimation of analysts by 1 cent. It also posted revenue of $37.06 billion for last three months of the year, almost 1 billion more than consensus estimate of $36.06 billion. During the similar quarter last year, the health care company reported earnings of $1.12 per share. However, its revenue was up by 12.9% on annual basis. Overall, analysts predict that CVS will be able to capture the earnings per share figure of $5.16 for the fiscal year 2015.

The American retailer and health care company declared its quarterly dividends, to be paid on 4^th May Monday. Shareholders on board as of 24^th April will be given $0.35 dividend against each share they own. This signifies an annual dividend of $1.40 and 1.37% yield.

CVS Health Corp (NYSE:CVS) stock was trading at $101.90 on market close Friday 6^th March. The health care company has a 52 week low and high of $72.05 and $104.84 respectively. The share has a 50-day and 200-day average of $101 and $90. It has a market cap of $116.17 billion and P/E ratio equals to 25.74 with almost 4.50 million shares exchanging hand in average 30 days.